1.
Ultra low-cost artificial leg developed
SAN ANTONIO, April 9 (UPI) -- U.S. researchers say they are testing a viral therapy for a lethal lung cancer.
Researchers at the Cancer Therapy & Research Center at the University of Texas Health Science Center at San Antonio have begun enrolling up to 55 patients with squamous non-small cell lung cancer for a clinical trial of the viral treatment -- Reolysin -- used in combination with two chemotherapy drugs.
"The study offers new hope for this group of patients with lung cancer," Dr. Alain Mita said in a statement.
Reolysin, an experimental treatment derived from a reovirus that replicates so prolifically in a cancer cell it causes the cell to burst, directly kills many types of cancer cells but leaves normal cells unharmed and works synergistically with other cancer therapies.
The trial -- part of a broad collaboration with Oncolytics Biotech Inc., a cancer pharmaceuticals company based in Calgary, Alberta -- is one of a group of five phase 2 studies.
|
|
|
|
|
|
| Additional Health News Stories | |
WASHINGTON, Feb. 10 (UPI) --
Republican presidential contender Mitt Romney told a conservative audience in Washington Friday he would make sweeping changes to Medicare and Social Security.
|
LOS ANGELES, Feb. 10 (UPI) --
Pop icon Madonna says she "wasn't happy" after rapper M.I.A. flipped her middle finger at a camera during the Super Bowl halftime show in Indianapolis.
|
BIRMINGHAM, England, Feb. 10 (UPI) --
A British company said it is opening salons across England dedicated to the tattooing the scalps of bald men to make it look like they have short hair.
|
WASHINGTON, Feb. 10 (UPI) --
The Nuclear Regulatory Commission approved the construction of two new nuclear reactors, the first to be built in the United States since 1978.
|
| Stories | Photos | People | Comments |
View Caption
